Containing Pandemic Influenza at the Source

Highly pathogenic avian influenza A (subtype H5N1) is threatening to cause a human pandemic of potentially devastating proportions. We used a stochastic influenza simulation model for rural Southeast Asia to investigate the effectiveness of targeted antiviral prophylaxis, quarantine, and pre-vaccination in containing an emerging influenza strain at the source. If the basic reproductive number (R0) was below 1.60, our simulations showed that a prepared response with targeted antivirals would have a high probability of containing the disease. In that case, an antiviral agent stockpile on the order of 100,000 to 1 million courses for treatment and prophylaxis would be sufficient. If pre-vaccination occurred, then targeted antiviral prophylaxis could be effective for containing strains with an R0 as high as 2.1. Combinations of targeted antiviral prophylaxis, pre-vaccination, and quarantine could contain strains with an R0 as high as 2.4.

[1]  R. Sharrar.  National influenza experience in the USA, 1968-69. , 1969, Bulletin of the World Health Organization.

[2]  R. Bailey,et al.  Hong Kong influenza: the epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 Asian influenza epidemic. , 1970, American journal of epidemiology.

[3]  E. D. Kilbourne,et al.  The Influenza viruses and influenza , 1975 .

[4]  A. Langworthy,et al.  An influenza simulation model for immunization studies. , 1976, American journal of epidemiology.

[5]  I. Longini,et al.  An optimization model for influenza A epidemics , 1978 .

[6]  L. A. Rvachev,et al.  A mathematical model for the global spread of influenza , 1985 .

[7]  AC Tose.  Cell , 1993, Cell.

[8]  A. Chamratrithirong,et al.  Internal Migration in Thailand , 1994, Asian and Pacific migration journal : APMJ.

[9]  K. Richter,et al.  National migration survey of Thailand. , 1995 .

[10]  M. Halloran,et al.  Design and interpretation of vaccine field studies. , 1999, Epidemiologic reviews.

[11]  A. Monto,et al.  Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. , 1999, JAMA.

[12]  V. Yu,et al.  Antimicrobial Therapy and Vaccines , 1999 .

[13]  Stephen J. Walsh,et al.  Spatial arrangement of social and economic networks among villages in Nang Rong District, Thailand , 2000, Soc. Networks.

[14]  A. Monto,et al.  Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. , 2000, The New England journal of medicine.

[15]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[16]  E. Garman,et al.  The Origin and Control of Pandemic Influenza , 2001, Science.

[17]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[18]  F. Hayden,et al.  Perspectives on antiviral use during pandemic influenza. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[19]  R. Webster.  A Molecular Whodunit , 2001, Science.

[20]  J. Oxford,et al.  Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. , 2001, JAMA.

[21]  G. Evan,et al.  Apoptosis. Till death us do part. , 2001, Science.

[22]  A. Nizam,et al.  Community interventions and the epidemic prevention potential. , 2002, Vaccine.

[23]  Weber.  Antimicrobial Therapy and Vaccines , 2002 .

[24]  R. Webster,et al.  Are We Ready for Pandemic Influenza? , 2003, Science.

[25]  Rustom Antia,et al.  The role of evolution in the emergence of infectious diseases , 2003, Nature.

[26]  I. Longini,et al.  The critical vaccination fraction for heterogeneous epidemic models. , 2003, Mathematical biosciences.

[27]  C. Fraser,et al.  Public Health Risk from the Avian H5N1 Influenza Epidemic , 2004, Science.

[28]  M. Enserink.  Avian Influenza: Catastrophe Waiting in the Wings? , 2004, Science.

[29]  C. Viboud,et al.  A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.

[30]  K. Stöhr,et al.  Will Vaccines Be Available for the Next Influenza Pandemic? , 2004, Science.

[31]  J. Robins,et al.  Transmissibility of 1918 pandemic influenza , 2004, Nature.

[32]  A. Nizam,et al.  Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.

[33]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[34]  K. Stöhr.  Avian influenza and pandemics--research needs and opportunities. , 2005, The New England journal of medicine.

[35]  A. Monto.  The threat of an avian influenza pandemic. , 2005, The New England journal of medicine.

[36]  Prasert Auewarakul,et al.  Probable person-to-person transmission of avian influenza A (H5N1). , 2005, The New England journal of medicine.

[37]  M Elizabeth Halloran,et al.  Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups , 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.

[38]  M. Kunze,et al.  European Physical Journal C Manuscript No. Observation of Resonances in the Reaction Pp ! 0 at 1.94 Gev =c the Crystal Barrel Collaboration , 2007 .